JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
MDGL Financials - Madrigal Pharmaceuticals Income & Cash Flow | Ledgeburg
MDGL - Madrigal Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary MDGL Stock
Financials
Financials MDGL Stock
Loading...
Loading...
Income Statement
Income Statement MDGL Stock
Balance Sheet
Balance Sheet MDGL Stock
Cash Flow Statement
Cash Flow Statement MDGL Stock
Loading...
Loading...
Home
Stocks
Madrigal Pharmaceuticals, Inc. (MDGL)
Financials
Financials of MDGL
Loading...
Loading...
Loading...
Loading...
Revenue
$958.403M
Operating Income
$-300.097M
Net Income
$-288.284M
Share Count (Basic)
22.43431M
Operating Cash Flow
$-189.553M
Free Cash Flow
$-190.02M
Cash And Short-Term Equivalents
$198.693M
Total Debt
$339.881M
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
1B
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
100M
200M
300M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-450M
-400M
-350M
-300M
-250M
Annual
Quarterly
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
100%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-120M
-100M
-80M
-60M
-40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26